All News

A look at one of the most common forms of skin cancer.

Medication management and vaccination services among top services.

Treating cancer is costly enough, but the side effects also tax the economic system.

CVS to emphasize HealthHUB and chains test stand-alone pharmacies.

Fourth filgrastim biosimilar from Sandoz, expected ASAP.

Could lead to falsely high or low results, especially troponin assays.

Approved for ages 65 and older.

Practical tips to help keep patients safe.

Savings totaled $293 billion in 2018.

Analysts now speculating potential next moves.

First and currently only rifabutin-based H. pylori therapy approved.

Cancer type and chemotherapy are leading risk factors.

Vaccination significantly reduces the risk of the disease.

Why research says understanding the overlap between Kaposi sarcoma-associated herpesvirus (KSHV) and human herpesvirus 8 (HHV8)-positive large B-cell lymphomas and associated diseases may lead to better outcomes.

New research indicates lower survival in patients with slower gait speed.

Site will offer CBD education and product marketing.

Walgreens and a California chain announced closures this week.

Delayed-release oral capsules for various forms of the disease.

Statin regimens may need tweaking to deliver optimal results. 

Fewer tracheobronchial branches may be a genetically-related risk factor.

Regular exercise can be an effective way to delay the onset and acceleration of COPD.

"I’ve yet to meet a pharmacist who ever had this covered in pharmacy school," writes Kreckel. 

Results presented at the 2019 NCPA Annual Convention

Governor Pritzker pushing for lighter pharmacy workloads.

Common collaborations include allergy, antibiotic, and opiate consultations.

Commercial launch suspended due to manufacturer liquidity.

What execs and experts think of the future of drug costs.

Fifth company warned about unsubstantiated claims this year.